| scholarly article | Q13442814 |
| P50 | author | George A. Calin | Q64785850 |
| Suranganie Dharmawardhane | Q65969967 | ||
| P2093 | author name string | Linette Castillo-Pichardo | |
| Luis Cubano | |||
| Ailed Cruz-Collazo | |||
| Columba de la Parra | |||
| Roxana Redis | |||
| P2860 | cites work | Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. | Q36689118 |
| Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells | Q36896100 | ||
| Multi-targeted therapy of cancer by genistein | Q36955543 | ||
| Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells | Q37091712 | ||
| BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer | Q37148045 | ||
| Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells | Q37195192 | ||
| Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens | Q37245953 | ||
| Soy, phytoestrogens and metabolism: A review | Q37477663 | ||
| The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies | Q37536156 | ||
| Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer. | Q37586065 | ||
| Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis. | Q37593455 | ||
| Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells | Q37650697 | ||
| A brief historical overview of the past two decades of soy and isoflavone research | Q37756426 | ||
| Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases | Q38122433 | ||
| The multiple roles of microRNA-155 in oncogenesis | Q38145349 | ||
| Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. | Q38300255 | ||
| Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia | Q38351879 | ||
| 3-dimensional tissue is formed from cancer cells in vitro on Gelfoam®, but not on Matrigel™. | Q39027149 | ||
| Genistein down-regulates miR-223 expression in pancreatic cancer cells | Q39129054 | ||
| Oncogenic MicroRNA-27a is a target for genistein in ovarian cancer cells | Q39188964 | ||
| Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells | Q39247260 | ||
| Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway | Q39349283 | ||
| Physiological concentrations of genistein and 17β-estradiol inhibit MDA-MB-231 breast cancer cell growth by increasing BAX/BCL-2 and reducing pERK1/2. | Q39366190 | ||
| MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling | Q39393414 | ||
| miRNAs differentially expressed in prostate cancer cell lines after soy treatment | Q39453919 | ||
| Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. | Q39487856 | ||
| Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line | Q39542456 | ||
| AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines. | Q39677107 | ||
| Modulation of microRNA associated with ovarian cancer cells by genistein. | Q39748329 | ||
| Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells | Q39779908 | ||
| Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. | Q39819560 | ||
| MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? | Q39834203 | ||
| Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification | Q39991815 | ||
| Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. | Q40365994 | ||
| Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. | Q40938787 | ||
| MicroRNAs 221/222 and Genistein-Mediated Regulation of ARHI Tumor Suppressor Gene in Prostate Cancer | Q41412852 | ||
| Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats | Q44048182 | ||
| MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer | Q24603354 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity | Q31015825 | ||
| microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers | Q33576814 | ||
| Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERα expression and induction of apoptosis | Q33837460 | ||
| Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols | Q33967930 | ||
| Quantitative proteomics identify novel miR-155 target proteins. | Q33974878 | ||
| Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study | Q34060204 | ||
| Inhibition of cancer cell invasion and metastasis by genistein | Q34105995 | ||
| Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells | Q34126469 | ||
| Individual and combined soy isoflavones exert differential effects on metastatic cancer progression | Q34152723 | ||
| The oncogenic role of miR-155 in breast cancer | Q34284424 | ||
| Is soy consumption good or bad for the breast? | Q34308323 | ||
| Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. | Q34396048 | ||
| Serum microRNA-155 as a potential biomarker to track disease in breast cancer | Q34447755 | ||
| PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation | Q34514602 | ||
| Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein | Q34559384 | ||
| Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer | Q34565728 | ||
| Apoptosis by dietary agents for prevention and treatment of prostate cancer | Q34614042 | ||
| Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer | Q34648583 | ||
| Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells | Q34773465 | ||
| miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. | Q34923751 | ||
| Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. | Q34925594 | ||
| Isoform-level microRNA-155 target prediction using RNA-seq | Q34947224 | ||
| Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice | Q35883554 | ||
| Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. | Q35906004 | ||
| The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G | Q36451858 | ||
| Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis | Q36642452 | ||
| 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells | Q45090553 | ||
| Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture | Q46061285 | ||
| Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China | Q46845362 | ||
| Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. | Q51755864 | ||
| Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio. | Q53075798 | ||
| Report on the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. | Q53199565 | ||
| Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro | Q71906434 | ||
| Plasma concentrations of phyto-oestrogens in Japanese men | Q72656995 | ||
| Higher bioavailability of isoflavones after a single ingestion of aglycone‐rich fermented soybeans compared with glucoside‐rich non‐fermented soybeans in Japanese postmenopausal women | Q82590970 | ||
| MicroRNAs--the micro steering wheel of tumour metastases | Q83429939 | ||
| Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats | Q84419380 | ||
| Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes | Q87367036 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 154-164 | |
| P577 | publication date | 2016-01-15 | |
| P1433 | published in | Nutrition and Cancer | Q7070508 |
| P1476 | title | Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein | |
| P478 | volume | 68 |
| Q89509558 | Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression |
| Q90597836 | Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses |
| Q39354574 | Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer. |
| Q41529803 | Dietary Isoflavones and Breast Cancer Risk |
| Q61453305 | Effects of three flavonoids from an ancient traditional Chinese medicine on geriatric diseases |
| Q52568075 | Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis. |
| Q92702834 | Microglia Mediated Neuroinflammation: Focus on PI3K Modulation |
| Q92187885 | Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances |
| Q38938169 | New insights into vitamin D anticancer properties: focus on miRNA modulation. |
| Q90414901 | Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach |
| Q93081258 | Progress in Research on the Role of Flavonoids in Lung Cancer |
| Q47984355 | Role of phytochemicals in the modulation of miRNA expression in cancer |
| Q58087797 | Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis |
| Q98289743 | Targeting micro-RNAs by natural products: a novel future therapeutic strategy to combat cancer |
| Q37705845 | The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells |
| Q91643832 | miRNAs and Novel Food Compounds Related to the Browning Process |
Search more.